In the near future, the CBD, THC or other cannabinoids you consume in edibles or medications may not be derived from cannabis at all, but grown in a laboratory.
Kevin Chen, CEO and co-founder of Hyasynth Bio, describes the Montreal-based start-up as "focused on engineering strains of yeast to produce the active compounds of cannabis without having to grow plants."
Recent comments
12 weeks 1 day ago
16 weeks 2 days ago
17 weeks 6 days ago
18 weeks 10 hours ago
30 weeks 2 days ago
36 weeks 13 hours ago
47 weeks 14 hours ago
47 weeks 6 days ago
49 weeks 4 days ago
50 weeks 14 hours ago